Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Patent Publication Number 20210308127
US 20210308127 A1Patent NumberUS 11400087 B2
Application Number17304606
Filled DateJun 23, 2021
Priority DateSep 24, 2013
Publication DateOct 7, 2021
Original AssigneeOtsuka Holdings Co. Ltd.
Current AssigneeOtsuka Holdings Co. Ltd.
Inventor/ApplicantsArash Raoufinia
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.